Morphological condition of the skin following a 4-week opioid exposure in an experimental study
 
More details
Hide details
1
Danylo Halytsky Lviv National Medical University, Ukraine
 
 
Submission date: 2024-12-14
 
 
Final revision date: 2025-01-14
 
 
Acceptance date: 2025-02-11
 
 
Publication date: 2025-02-28
 
 
Corresponding author
Ivan S Diskovskyi   

Department of Operative Surgery with Topographic Anatomy, Danylo Halytsky Lviv National Medical University, Ukraine
 
 
Wiadomości Lekarskie 2025;(2):347-352
 
KEYWORDS
TOPICS
other
 
ABSTRACT
Aim:
The study aimed to determine the peculiarities of the micro- and ultrastructural organization of the skin under conditions of a four-week administration of an opioid to experimental animals.

Material and methods:
The study material included skin samples of white rats with injected vascular beds, histological preparations, and ultrathin skin sections. Research methods involved injection techniques, histological analysis, electron microscopy, morphometric measurements, and statistical analysis.

Results:
The results of the study revealed that after four weeks of nalbuphine administration to experimental animals, blood stasis was observed in the lumen of capillaries and venules, along with perivascular edema and perivascular infiltrates consisting of neutrophils, lymphocytes, macrophages, and tissue basophils. The electron density of the nuclei and cytoplasm of granular layer keratinocytes was reduced, keratinocytes in the stratum spinosum acquired a rounded shape, with some nuclei appearing shrunken and hyperchromatic, and their cytoplasm exhibiting vacuolization. In the reticular layer, thickened bundles of collagen fibers were observed, with localized swelling and fragmentation of the collagen fibers. Excessive formation of scales was noticed in the stratum corneum. The papillary layer of the dermis contained numerous mast cells and lymphocytes near blood vessels.

Conclusions:
Four weeks of nalbuphine administration induces irreversible pathological processes in all skin components.
REFERENCES (27)
1.
Slat S, Yaganti A, Thomas J, Helminski D. Opioid Policy and Chronic Pain Treatment Access Experiences: A Multi-Stakeholder Qualitative Analysis and Conceptual Model. Journal of Pain Research. 2021;14:1161–1169.
 
3.
Liu X, Hu J, Hu X, Li R. Preemptive Intravenous Nalbuphine for the Treatment of Post-Operative Visceral Pain: A Multicenter, Double-Blind, Placebo-Controlled, Randomized Clinical Trial. Pain therapy. 2021. https://doi.org/10.1007/s40122....
 
4.
Larsen D, Maani ChV. Nalbuphine. In: StatPearls [Internet]. Treasure Island (FL) : StatPearls Publishing. 2021. URL: https://pubmed.ncbi.nlm.nih.go....
 
5.
Béliveau A, Castilloux A-M, Tannenbaum C, Vincent Ph. Predictors of long-term use of prescription opioids in the community-dwelling population of adults without a cancer diagnosis: a retrospective cohort study. CMAJ OPEN. 2021;9(1):E96–E106. doi: https://doi.org/10.9778/cmajo.....
 
6.
Beck TC, Hapstack MA, Dix TA. Therapeutic Potential of Kappa Opioid Agonists. Pharmaceuticals (Basel). 2019;12(2):95. doi: 10.3390/ph12020095. 237.
 
7.
Davis MP, Fernandez C, Regel S. et al. (2018) Does nalbuphine have a niche in managing pain? J. Opioid Manag., 14(2): 143–151. www.umj.com.ua/uk/publikatsia-253406-deyaki-praktichni-aspekti-zastosuvannya-opioyidnih-analgetikiv-negajnogo-ta-podovzhenogo-vivilnennya-pri-hronichnomu-bolovomu-sindromi.
 
8.
Seth P, Rudd RA, Noonan RK, Haegerich TM. Quantifying the Epidemic of Prescription Opioid Overdose Deaths. Am J Public Health. 2018;108(4):500–2.
 
9.
Taqi MM, Faisal M, Zaman H. OPRM1 A118G Polymorphisms and Its Role in Opioid Addiction: Implication on Severity and Treatment Approaches. Pharmacogenomics and Personalized Medicine. 2019;12:361–368.
 
10.
doi: 10.2147/PGPM.S198654.
 
11.
Shekarchizadeh H, Khami MR, Mohebbi SZ, Ekhtiari H, Virtanen JI. Oral health status and its determinants among opiate dependents: a cross-sectional study. BMC Oral Health. 2019;19(1):5. doi.org/10.1186/s12903-018-0691-3.
 
12.
.Ciurylo W, Noh E. Opioid-associated amnestic syndrome. Cureus J. Med. Sci. 2021;13:16714. [Google Scholar] [CrossRef].
 
13.
Kreek MJ, Reed B, Butelman ER. Current status of opioid addiction treatment and related preclinical research. Science Advances. 2019;5(10):9140.
 
14.
doi: 10.1126/sciadv.aax9140.
 
15.
Hurtado I, Garcia-Sempere A, Peiro S, Sanfelix-Gimeno G. Increasing Trends in Opioid Use From 2010 to 2018 in the Region of Valencia, Spain: A Real-World, Population-Based Study. Frontiers in Pharmacology. 2020;11:61255.
 
16.
Bedene A, van Dorp ELA, Faquih T, Cannegieter SC. Causes and consequences of the opioid epidemic in the Netherlands: a population-based cohort study. Scientific Reports. 2020;10(1):15309. doi: 10.1038/s41598-020-72084-6.
 
17.
Plein LM, Rittner HL. Opioids and the immune system – friend or foe. British Journal of Pharmacology. 2018;175(14):2717–2725. doi: 10.1111/bph.13750.
 
18.
Alasmari F, Alasmari MS, Assiri MA, Alswayyed M, Ahamad SR, Alhumaydhi AI, Arif BI, Aljumayi SR, AlAsmari AF, Ali N. et al. Liver metabolomics and inflammatory profiles in mouse model of fentanyl overdose treated with Beta-lactams. Metabolites 2023;13:965. [Google Scholar] [CrossRef].
 
19.
Vandenbosch M, Pajk S, Van den Bogaert W, Wuestenbergs J, Van de Voorde W, Cuypers E. Post-mortem analysis of opioids and metabolites in skeletal tissue. J. Anal. Toxicol. 2022;46:783–790. [Google Scholar] [CrossRef].
 
20.
Kirla KT, Erhart C, Groh KJ, Stadnicka-Michalak J, Eggen RIL, Schirmer K, Kraemer T. Zebrafish early life stages as alternative model to study ‘designer drugs’: Concordance with mammals in response to opioids. Toxicol. Appl. Pharmacol. 2021;419:115483. [Google Scholar] [CrossRef].
 
21.
Li J, Zeng X, Yang X, Ding H. Lycopene ameliorates skin aging by regulating the insulin resistance pathway and activating SIRT1. Food Funct. 2022;13(21):11307–11320. Doi: 10.1039/d2fo01111e.
 
22.
Korolev AI, Fedorovich AA, Gorshkov AY, Dadaeva VA, Omelyanenko KV, Chashchin MG, Drapkina OM. Structural and functional state of various parts of skin microcirculation at an early stage of hypertension in working-age men. Microvasc. Res. 2023;145:104440. Doi: 10.1016/j.mvr.2022.104440.
 
23.
Feng T, Zeng S, Ding J, Chen, G, Wang B, Wang D, Li X, Wang K. Comparative analysis of the effects of opioids in angiogenesis. BMC Anaesthesiol. 2021;21:257. [Google Scholar] [CrossRef].
 
24.
Vereshchaka V.V. Pathophysiological mechanisms of redusing resistance of skin capillaries in microcirculation impairments. Physiological journal.2000; 46(6):116–118.
 
25.
Vereshchaka V. The influence of hypertension on the development of morphological changes in skin: histochemical investigation. Biology. 2014;2(67):9–13.
 
26.
Ivasivka KhP, Paltov YV, Kryvko YY. Influence of the opioid analgesic molecule on organ structure within the spectrum of action. World Science. 2019;2(9(49)):15–19.
 
27.
Fik VB, Paltov YeV, Kryvko YuYa. Ultrastructural organization features of periodontal tissues after twelve weeks of opiod influence. The world of medicine and biology. 2020;3(73):234–237.
 
eISSN:2719-342X
ISSN:0043-5147
Journals System - logo
Scroll to top